MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
75 hedge funds and large institutions have $72.9M invested in Marinus Pharmaceuticals, Inc in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
60% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 25
Holders
75
Holding in Top 10
1
Calls
$398K
Puts
$144K
Top Buyers
| 1 | +$2.78M | |
| 2 | +$2.21M | |
| 3 | +$2.2M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.44M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$749K |
Top Sellers
| 1 | -$4.78M | |
| 2 | -$2.5M | |
| 3 | -$1.72M | |
| 4 |
Goldman Sachs
New York
|
-$954K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$753K |